Title : Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus cholinesterase inhibition to reduce neurologic decline in Alzheimer's - Butler_2021_Contemp.Clin.Trials__106488 |
Author(s) : Butler T , Goldberg JD , Galvin JE , Maloney T , Ravdin L , Glodzik L , de Leon MJ , Hochman T , Bowen RL , Atwood CS |
Ref : Contemp Clin Trials , :106488 , 2021 |
Abstract : Butler_2021_Contemp.Clin.Trials__106488 |
ESTHER : Butler_2021_Contemp.Clin.Trials__106488 |
PubMedSearch : Butler_2021_Contemp.Clin.Trials__106488 |
PubMedID: 34166841 |
Butler T, Goldberg JD, Galvin JE, Maloney T, Ravdin L, Glodzik L, de Leon MJ, Hochman T, Bowen RL, Atwood CS (2021)
Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus cholinesterase inhibition to reduce neurologic decline in Alzheimer's
Contemp Clin Trials
:106488
Butler T, Goldberg JD, Galvin JE, Maloney T, Ravdin L, Glodzik L, de Leon MJ, Hochman T, Bowen RL, Atwood CS (2021)
Contemp Clin Trials
:106488